Challenge of treatment de-escalation in inflammatory bowel diseases

被引：0
|
作者：
Reenaers, Catherine [1 ]
Louis, Edouard [1 ]
机构：
[1] Univ Liege, Univ Hosp CHU & GIGA Inst, Liege, Belgium
来源：
GUT | 2025年
关键词：
IBD CLINICAL; INFLIXIMAB; CROHN'S DISEASE; ULCERATIVE COLITIS; CROHNS-DISEASE; OPEN-LABEL; INFLIXIMAB; MULTICENTER; WITHDRAWAL; REMISSION; THERAPY;
D O I：
10.1136/gutjnl-2024-334358
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Treatment de-escalation in inflammatory bowel diseases
    Abitbol, Vered
    PRESSE MEDICALE, 2018, 47 (11-12): : 931 - 933
  • [2] De-escalation of Therapy in Inflammatory Bowel Disease
    Frias Gomes C.
    Colombel J.-F.
    Torres J.
    Current Gastroenterology Reports, 2018, 20 (8)
  • [3] De-escalation of Biologic Treatment in Inflammatory Bowel Disease: A Comprehensive Review
    Gisbert, Javier P.
    Chaparro, Maria
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (04): : 642 - 658
  • [4] De-escalation of medical therapy in inflammatory bowel disease
    Gomes, Catarina Frias
    Chapman, Thomas P.
    Satsangi, Jack
    CURRENT OPINION IN PHARMACOLOGY, 2020, 55 : 73 - 81
  • [5] Predictors of sustained remission after infliximab de-escalation in patients with inflammatory bowel diseases
    Kantasiripitak, W.
    Outtier, A.
    Thomas, D.
    Sabino, J.
    Vermeire, S.
    Ferrante, M.
    Dreesen, E.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I485 - I485
  • [6] Predictors of sustained remission after infliximab de-escalation in patients with inflammatory bowel diseases
    Kantasiripitak, W.
    Outtier, A.
    Thomas, D.
    Sabino, J.
    Vermeire, S.
    Ferrante, M.
    Dreesen, E.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I485 - I485
  • [7] Model-informed dosage de-escalation of infliximab in patients with inflammatory bowel diseases
    Wang, Z.
    De Greef, I
    Kantasiripitak, W.
    Wicha, S. G.
    Tops, S.
    Nigro, M.
    Outtier, A.
    Verstockt, B.
    Sabino, J.
    Thomas, D.
    Vermeire, S.
    Ferrante, M.
    Dreesen, E.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1655 - i1656
  • [8] De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease
    Miyatani, Yusuke
    Kobayashi, Taku
    GUT AND LIVER, 2023, 17 (02) : 181 - 189
  • [9] De-escalation of immunomodulator and biological therapy in inflammatory bowel disease
    Chapman, Thomas P.
    Gomes, Catarina Frias
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01): : 63 - 79
  • [10] De-escalation of biological therapy in Inflammatory Bowel Disease patients following prior escalation
    Thomas, P.
    Smits, L.
    Groen, M. Te
    West, R.
    Russel, M.
    Jansen, J.
    Romkens, T.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S086 - S086
12345